MedPath

PHARIXIA

PHARIXIA

Approved
DIN Number

02229777

Drug Class

Human

Market Date

Dec 2, 1996

Company
HC

pendopharm division of pharmascience inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02229777
AIG Number0113801001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A01AD02 BENZYDAMINE
Product Specifications
Dosage FormMouthwash/Gargle
Route of AdministrationBuccal
AHFS Classification52:08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

BENZYDAMINE HYDROCHLORIDEActive
Strength: 0.15 % / W/V
Monograph: BENZYDAMINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.